131 related articles for article (PubMed ID: 16822576)
1. Antibodies for angiogenesis inhibition, vascular targeting and endothelial cell transcytosis.
Trachsel E; Neri D
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):735-54. PubMed ID: 16822576
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis: an update and potential drug approaches (review).
Abdelrahim M; Konduri S; Basha R; Philip PA; Baker CH
Int J Oncol; 2010 Jan; 36(1):5-18. PubMed ID: 19956828
[TBL] [Abstract][Full Text] [Related]
3. Use of a monoclonal antibody specific for activated endothelial cells to quantitate angiogenesis in vivo in zebrafish after drug treatment.
Seng WL; Eng K; Lee J; McGrath P
Angiogenesis; 2004; 7(3):243-53. PubMed ID: 15609079
[TBL] [Abstract][Full Text] [Related]
4. Antibody-Based targeting of angiogenesis.
Halin C; Neri D
Crit Rev Ther Drug Carrier Syst; 2001; 18(3):299-339. PubMed ID: 11442202
[TBL] [Abstract][Full Text] [Related]
5. [VEGF, anti-vEGF and diseases].
Corvol P
Bull Acad Natl Med; 2008 Feb; 192(2):289-300; discussion 300-2. PubMed ID: 18819684
[TBL] [Abstract][Full Text] [Related]
6. [Targeting angiogenesis in oncology].
Fayette J; Soria JC; Armand JP
Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
[TBL] [Abstract][Full Text] [Related]
7. Taking down tumors: vascular disrupting agents entering clinical trials.
O'Hanlon LH
J Natl Cancer Inst; 2005 Sep; 97(17):1244-5. PubMed ID: 16145041
[No Abstract] [Full Text] [Related]
8. Basic and therapeutic aspects of angiogenesis.
Potente M; Gerhardt H; Carmeliet P
Cell; 2011 Sep; 146(6):873-87. PubMed ID: 21925313
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
Abu Lila AS; Ishida T; Kiwada H
Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
[TBL] [Abstract][Full Text] [Related]
10. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
11. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
12. Novel anti-denatured collagen humanized antibody D93 inhibits angiogenesis and tumor growth: An extracellular matrix-based therapeutic approach.
Pernasetti F; Nickel J; Clark D; Baeuerle PA; Van Epps D; Freimark B
Int J Oncol; 2006 Dec; 29(6):1371-9. PubMed ID: 17088974
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis: an organizing principle for drug discovery?
Folkman J
Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis at endothelial cell level.
Jekunen A; Kairemo K
Microsc Res Tech; 2003 Jan; 60(1):85-97. PubMed ID: 12500265
[TBL] [Abstract][Full Text] [Related]
15. Angiotherapeutics from natural products: from bench to clinics?
Bernas G
Clin Hemorheol Microcirc; 2003; 29(3-4):199-203. PubMed ID: 14724342
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
17. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
18. Tumour vascular targeting.
Neri D; Bicknell R
Nat Rev Cancer; 2005 Jun; 5(6):436-46. PubMed ID: 15928674
[TBL] [Abstract][Full Text] [Related]
19. Potential role of vascular targeted therapy to combat against tumor.
Chen B; Jin H; Wu K
Expert Opin Drug Deliv; 2009 Jul; 6(7):719-26. PubMed ID: 19538038
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic application of noncytotoxic molecular targeted therapy in gliomas: growth factor receptors and angiogenesis inhibitors.
Idbaih A; Ducray F; Sierra Del Rio M; Hoang-Xuan K; Delattre JY
Oncologist; 2008 Sep; 13(9):978-92. PubMed ID: 18779539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
